Article

Compliance likely an issue when amblyopia therapy fails

When treating a child with amblyopia, what steps do you take when the Pediatric Eye Disease Investigator Group (PEDIG) guidelines do not work? The first thing to consider is whether you're getting poor compliance with your therapy, said Lionel Kowal, MD, FRACOphth, FRACS, Ophthalmology Eye and Ear Hospital, Melbourne, Australia.

When treating a child with amblyopia, what steps do you take when the Pediatric Eye Disease Investigator Group (PEDIG)guidelines do not work? The first thing to consider is whether you're getting poor compliance with therapy, said LionelKowal, MD, FRACOphth, FRACS, Ophthalmology Eye and Ear Hospital, Melbourne, Australia.

With patching, for example, Dr. Kowal said documentation in parent-kept diaries tends to overestimate the actual patchingtime. That could explain why in some studies, 2 hours of patching yields the same therapeutic results as 6 hours.

"Parents don't like parading an obviously defective child," Dr. Kowal said. "They also don't like to be 'mean' to theirchildren. So it's a tough situation for everyone involved.

"Sometimes we find that the best way to get your therapy to work is to find a way to help parents maintain enthusiasm for thetask," he said.

Other measures to consider if you are following the PEDIG guidelines but are not achieving satisfactory results, according toDr. Kowal:

  • If you're already patching, try atropine.
  • If you're using atropine, try patching.
  • Look for missed organic factors.
  • Correct the patient's strabismus.
  • In severe cases, consider refractive surgery.

Finally, remember the parents. "You must find a way to keep the therapeutic environment alive," Dr. Kowal said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
© 2025 MJH Life Sciences

All rights reserved.